Recent studies have reported that REST can inhibit the occurrence of tumors, and REST gene deletion or mutation is closely related to the occurrence of many tumors such as small-cell lung cancer [16], prostate cancer [17], and ovarian cancer [18]. This evidence concerns the gene REST and ovarian carcinoma.